Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$12.14
▾0.40 (3.19%)
Last trade: 20/12, 9:26PM
Market cap
$1.55b
Market closed
Talk to Neuren Pharmaceuticals Limited directly.
Sign up to their Investor Hub for direct access to the Neuren Pharmaceuticals Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Neuren Pharmaceuticals Limited (NEU) is a biopharmaceutical company developing therapies for brain injury, neurodevelopmental and neurodegenerative disorders. NEU has two key drug products comprising NNZ-2566 and NNZ-2591. NEU has operations in New Zealand, Australia and the USA.
Address
PwC Tower 188 Quay St, Auckland, 1010, New Zealand
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$12.14
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.